Safety and Efficacy Study of a New Antiviral Drug to Prevent Cytomegalovirus Reactivation in Bone Marrow Transplanted Patients
Clinical trial NCT01063829 · COMPLETED
Trial details
- NCT number
- NCT01063829
- Sponsor
- AiCuris Anti-infective Cures AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-03-01
- Primary completion
- 2011-10-01
- Enrollment
- 133
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.